In-Situ Gel-New Formulation Trend

Authors

  • Azad Nabilal Dhage  Department of Pharmaceutics, Dr. Babasaheb Ambedkar Technological University, Lonere, Ashokrao Mane Institute of Pharmaceutical Sciences and Research, Save, Kolhapur, Maharashtra, India.
  • Zinat Isak Mulla  Department of Chemistry, Shivaji University, Kolhapur, Government College of Pharmacy, Vidyanagar, Karad, Satara, Maharashtra, India
  • Abhijeet Shashikant Kulkarni  Department of Pharmaceutics, Dr. Babasaheb Ambedkar Technological University, Lonere, Ashokrao Mane Institute of Pharmaceutical Sciences and Research, Save, Kolhapur, Maharashtra, India.
  • Aniket Ramesh Borge  Department of Pharmaceutics, Dr. Babasaheb Ambedkar Technological University, Lonere, Ashokrao Mane Institute of Pharmaceutical Sciences and Research, Save, Kolhapur, Maharashtra, India.
  • Mayur Krishnat Ghosalkar  Department of Pharmaceutics, Dr. Babasaheb Ambedkar Technological University, Lonere, Ashokrao Mane Institute of Pharmaceutical Sciences and Research, Save, Kolhapur, Maharashtra, India.

DOI:

https://doi.org//10.32628/IJSRST229697

Keywords:

Residence time; Systemic effects; Patient compliance.

Abstract

This review on in situ gel was written to fill in any gaps in the current body of knowledge, with a special emphasis on in-situ gelling systems that prolong the residence time of drugs at their targets. Drugs with very short half-lives and high solubility are especially interested in in-situ gels. The use of in-situ gelling systems as drug delivery systems for both local and systemic effects has recently been developed. The advantages of in-situ polymeric delivery systems, such as ease of administration, decreased frequency of administration, enhanced patient compliance, and comfort, have drawn the most attention in current in-situ gelling system development. The studies that evaluated the use and performance of these systems are summarized in this review. This review paper is prepared to highlight formulation considerations employed during the development of an in-vivo drug delivery system, pertinent biodegradable polymers for the sol-gel transition, characterization, assessment criteria, and commercial formulations of the in-vivo polymeric system.

References

  1. Peppas N, Langer R. New challenges inbiomaterials. Science1994; 263:171520.
  2. Zhidong L ,Jaiwei L, Shufang N, Hui L, PingtianD, Weisan P.Study of an Pharm alginate-HPMC based in situ gelling ophthalmic deliverysystem for gatifloxacin. Int J. 2006; 315:12-7.
  3. Sarasija S, Shyamala B. Nasal Drug Delivery: An Overview, Indian J Pharm.Sci. 2005, 67(1): 19-25.
  4. Wataru K, Yasuhiro K, Miyazaki S, Attwood D. Insitu gelling pectin formulations for oral sustained delivery of paracetamol. Drug Develop Ind Pharm2004;30:593-9.
  5. Rathore K.S. In situ Gelling Ophthalmic Drug Delivery System: An Overview, Int. J. Pharm. Pharm. Sci., 2011, 2(4):30¬34.
  6. Bhardwaj L. Sharma P. K. and Malviya R. A Short Review on Gastro Retentive Formulations for Stomach Specific Drug Delivery: Special Emphasis on Floating In situ Gel Systems, African J. Basic & Applied Sci., 2011,3(6): 300-312.
  7. Miyazaki S, Kawasaki N. Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int J Pharm, 220, 2001, 161-8.
  8. Kokate C.K., Purohit A. P., Gokhale S.B. Pharmacognocy. 14th Ed. Published by Nirali Prakashan, 137, 2008,141,146,152.
  9. Davies N.M., Farr S.J., Hadgraft J., Kellaway L.W. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions, Pharm. Res., 8(8), 1991, 1039– 1043.
  10. Shastri DH, Patel LD, Novel alternative to ocular drug delivery system: Hydrogel, Ind J Pharma Res, 2010; 2: 1-13.
  11. Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D, In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm, 229, 2001, 29-36.
  12. Grasdalen H, Smidsroed O. Gelation of gellan gum. Carbohydrate Polymers, 7, 1987, 371-93.
  13. Sechoy O, Tissie G, Sebastian C, Maurin F, Driot JY, Trinquand C. A new long acting ophthalmic formulation of carteolol containing Alginic acid. Int J Pharm, 207, 2000,109-16.
  14. Cohen S., Lobel E., Trevgoda A., Peled Y. A novel in-situ forming Ophthalmic drug delivery system from alginates undergoing gelation in the eye. Journal of Controlled Release., 44, 1997, 201-208.
  15. Grant G.T., Morris E.R., Rees D.A., Smith P.J.C., Thom D. Biological interactions between polysaccharides and divalent cations: The egg box model. FEBS Lett., 32, 1973,195-198.
  16. Al-Shamklani A, Bhakoo M, Tuboku MA, Duncan R. Evaluation of the biological properties of alginates andgellan and xanthan gum. Proc Int Symp Control Release Bioact Mater, 18, 1991, 213-4.
  17. Calonge M, The treatment of dry eye, Surv Ophthalmol, 45,2011, 227-239.
  18. Nanjawade BK, Manvi FV, Manjappa AS, Review of in-situ forming hydrogels for sustained ophthalmic drug delivery, J Control Rel, 122, 2007, 119-134.
  19. Sterile ophthalmic gel forming solution, Timoptic- XE;, 0.25% and 0.5%, (Timolol maleate ophthalmic gel forming solution), Merck and Company Inc. NJ08889: Whitehouse Station, USA.
  20. Ramesh CR, Zentner GM, Jeong B. Macro med, Inc. Biodegradable low molecular weight triblock poly (lactide-co- glycolide) polyethylene glycolcopolymers having reverse thermal gelation properties. US patent 6201072. 2001.
  21. Kumar L. Singh R.P. Singh S.G. and Kumar D. In situ Gel: A Novel System for Ocular Drug Delivery, Int. j. pharm. Sci. rev & res.,2011,9,(2):83-91.
  22. Patel P.B. Shastri D.H. Shelat P.K. and Shukla A.K. Development and Evaluation of PH Triggered In situ Ophthalmic Gel Formulation of Ofloxacin, Am. J. Pharm. Tech. Res., 2011, 1(4):430-445.
  23. Zarikar N. Katedeshmukh R. Kulkarni A. and Patel R. Ophthalmic In situ Drug Delivery System: A Review, Int. J. Pharm. Res. & Dev., 2013, 5(5):48 – 55.
  24. Talat F. Sadhana R.S. Azmat M.S. Nityanand Z. and Syed A. Formulation Development and Evaluation of In situ Ophthalmic Gel of Sodium Cromoglycate. Der Pharmacia Sinica, 2013, 4(2):109-118.
  25. Gupta A. and Manocha N. Formulation and Evaluation of In Situ Ophthalmic Drug Delivery System, Int. J. Pharm. Bio. Arch., 2012,3(4):715-718.
  26. Agarwal K. Mehta N. Namdev A. and Gupta A.K. In Situ Gel Formation for Ocular Drug Delivery System: An Overview, Asian J. Bio Pharm Sci., 2011, 1(4):01- 07.
  27. Rajeshwari N. Patil R. and Kumar S. In situ Gelling System: Novel Approach for Ophthalmic Drug Delivery, World J. Pharm. Pharma. Sci. 2014, 3(7):423-440.
  28. Rukari TG et al., A Review on ophthalmic In Situ Gels. American Journal of Pharma Reserch 2019; 9(02).
  29. Meshram S, Thorat S (2015) Ocular in Situ gels: Development, evaluation and advancements. Sch Acad J Pharm 4(7): 340-346.
  30. Gambhire S, Bhalerao K, Singh S (2013) In situ hydrogel: Different approaches to ocular drug delivery. Int J Pharmacy Pharm Sci 5(2): 27-36.
  31. Saini R, Saini S, Singh G, Banerjee A. (2015) In situ gels- a new trends in ophthalmic drug delivery systems. International Journal of Pharma Sciences and Research 6(5): 886-890.
  32. Kute PR, Gondkar SB, Saudagar RB (2015) Ophthalmic in-situ gel: an overview. World J Pharmacy Pharm Science 4: 549-568.
  33. Rabiah Bashir, Asmat Majeed, Tabasum Ali; Floating Oral In-Situ Gel : A Review Journal of Drug Delivery and Therapeutics 2019; 9(2): 442-443
  34. Chen W, Huang C, Su C, Li W and Hou S.Preparation and evaluation of a carbopol/hpmc based in situ gelling ophthalmic system for puerari: Yakugaku Zasshi. Pharmaceutical Society of Japan, 2007; 127(1):183-191.
  35. Rathod HV, Patel V, Modasia M. In situ gel as a novel approach of gastroretentive drug delivery: International Journal Of Pharmacy and Life Sciences, 2011; 1(8):440-447.
  36. Seth SD.Text book of pharmacology, Reed Elsevier Ltd.2005
  37. Shah DP, Jani GK. A newer application of physically modified gellan gum in tablet formulation using factorial design. ARS Pharmaceutica, 2010; 51(1):28-40.
  38. Marsha RJ, MS Philip B, Massersmith. In-situ forming biomaterials.Oral MaxillofacialSurg Clin N Am, 2002; 29-38.
  39. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm, 2000.
  40. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev, 2001; 53:321-39.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2022-12-30

Issue

Volume 9, Issue 6, November-December-2022

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Azad Nabilal Dhage, Zinat Isak Mulla, Abhijeet Shashikant Kulkarni, Aniket Ramesh Borge, Mayur Krishnat Ghosalkar, " In-Situ Gel-New Formulation Trend, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 9, Issue 6, pp.665-675, November-December-2022. Available at doi : https://doi.org/10.32628/IJSRST229697